Horizon Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
116.14
|
|
Average Rating
|
3.40
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
8
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
1.11
|
0.00
|
-1.11
|
-100.00%
|
|
2022-09-30
|
1.01
|
1.25
|
0.24
|
23.76%
|
|
2022-06-30
|
1.34
|
1.07
|
-0.27
|
-20.15%
|
|
2022-03-31
|
1.14
|
1.34
|
0.20
|
17.54%
|
|
2021-12-31
|
1.35
|
1.41
|
0.06
|
4.44%
|
|
2021-09-30
|
1.54
|
1.75
|
0.21
|
13.64%
|
|
2021-06-30
|
0.88
|
1.62
|
0.74
|
84.09%
|
|
2021-03-31
|
0.05
|
0.03
|
-0.02
|
-40.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
3.66
|
|
2021-12-31
|
4.81
|
|
2020-12-31
|
3.82
|
|
2019-12-31
|
1.99
|
|
2018-12-31
|
1.83
|
|
2017-12-31
|
1.17
|
|
2016-12-31
|
2.24
|
|
2015-12-31
|
1.93
|
|
2014-12-31
|
-2.68
|
|
2013-12-31
|
-1.24
|
|
2012-12-31
|
-2.40
|
|
2011-12-31
|
-9.93
|